CÉLULAS MADRE Y TERAPIA CELULAR
French Institute of Health and Medical Research
París, FranciaPublicaciones en colaboración con investigadores/as de French Institute of Health and Medical Research (8)
2018
-
Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria
Science Translational Medicine, Vol. 10, Núm. 459
2015
-
Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1
American Journal of Medical Genetics, Part A, Vol. 167, Núm. 2, pp. 296-312
2010
-
Novel TMEM67 mutations and genotype-phenotype correlates in meckelin-related ciliopathies
Human Mutation, Vol. 31, Núm. 5
2006
2005
-
Prenatal diagnosis of severe structural congenital malformations in Europe
Ultrasound in Obstetrics and Gynecology, Vol. 25, Núm. 1, pp. 6-11
-
Preventing neural tube defects in Europe: A missed opportunity
Reproductive Toxicology, Vol. 20, Núm. 3, pp. 393-402
-
Trends and geographic inequalities in the prevalence of Down syndrome in Europe, 1980-1999
Revue d'Epidemiologie et de Sante Publique
2004
-
Prenatal diagnostic procedures used in pregnancies with congenital malformations in 14 regions of Europe
Prenatal Diagnosis, Vol. 24, Núm. 11, pp. 908-912